Markel Group’s Johnson & Johnson JNJ Stock Holding History

Markel Group’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$155M	Hold	610,800	–	–	1.18%	24
2026 Q1	$149M	Hold	610,800	–	–	1.25%	22
2025 Q4	$126M	Hold	610,800	–	–	1.01%	32
2025 Q3	$113M	Hold	610,800	–	–	0.92%	36
2025 Q2	$93.3M	Hold	610,800	–	–	0.79%	39
2025 Q1	$101M	Hold	610,800	–	–	0.9%	34
2024 Q4	$88.3M	Hold	610,800	–	–	0.78%	37
2024 Q3	$99M	Hold	610,800	–	–	0.89%	35
2024 Q2	$89.3M	Hold	610,800	–	–	0.88%	36
2024 Q1	$96.6M	Hold	610,800	–	–	0.95%	34
2023 Q4	$95.7M	Hold	610,800	–	–	1.04%	28
2023 Q3	$95.1M	Hold	610,800	–	–	1.15%	25
2023 Q2	$101M	Hold	610,800	–	–	1.2%	24
2023 Q1	$94.7M	Hold	610,800	–	–	1.2%	25
2022 Q4	$108M	Hold	610,800	–	–	1.45%	22
2022 Q3	$99.8M	Hold	610,800	–	–	1.47%	23
2022 Q2	$108M	Hold	610,800	–	–	1.55%	20
2022 Q1	$108M	Hold	610,800	–	–	1.28%	23
2021 Q4	$104M	Hold	610,800	–	–	1.2%	24
2021 Q3	$98.6M	Hold	610,800	–	–	1.25%	22
2021 Q2	$101M	Hold	610,800	–	–	1.27%	21
2021 Q1	$100M	Hold	610,800	–	–	1.39%	20
2020 Q4	$96.1M	Hold	610,800	–	–	1.43%	17
2020 Q3	$90.9M	Hold	610,800	–	–	1.54%	19
2020 Q2	$85.9M	Hold	610,800	–	–	1.6%	17
2020 Q1	$80.1M	Hold	610,800	–	–	1.51%	16
2019 Q4	$89.1M	Hold	610,800	–	–	1.24%	20
2019 Q3	$79M	Hold	610,800	–	–	1.19%	21
2019 Q2	$85.1M	Hold	610,800	–	–	1.31%	20
2019 Q1	$85.4M	Hold	610,800	–	–	1.43%	18
2018 Q4	$78.8M	Hold	610,800	–	–	1.51%	17
2018 Q3	$84.4M	Hold	610,800	–	–	1.42%	17
2018 Q2	$74.1M	Hold	610,800	–	–	1.36%	18
2018 Q1	$78.3M	Hold	610,800	–	–	1.49%	18
2017 Q4	$85.3M	Hold	610,800	–	–	1.61%	16
2017 Q3	$79.4M	Hold	610,800	–	–	1.58%	17
2017 Q2	$80.8M	Hold	610,800	–	–	1.72%	14
2017 Q1	$76.1M	Hold	610,800	–	–	1.71%	14
2016 Q4	$70.4M	Hold	610,800	–	–	1.7%	14
2016 Q3	$72.2M	Hold	610,800	–	–	1.86%	15
2016 Q2	$74.1M	Hold	610,800	–	–	1.95%	14
2016 Q1	$66.1M	Buy	610,800 +5,600	+0.9%	+$580K	1.77%	15
2015 Q4	$62.2M	Buy	605,200 +23,000	+4%	+$2.31M	1.68%	18
2015 Q3	$54.3M	Buy	582,200 +8,000	+1%	+$774K	1.43%	23
2015 Q2	$56M	Hold	574,200	–	–	1.4%	22
2015 Q1	$57.8M	Hold	574,200	–	–	1.46%	21
2014 Q4	$60M	Hold	574,200	–	–	1.51%	20
2014 Q3	$61.2M	Hold	574,200	–	–	1.73%	18
2014 Q2	$60.1M	Hold	574,200	–	–	1.71%	19
2014 Q1	$56.4M	Sell	574,200 -6,400	-1%	-$593K	1.73%	19
2013 Q4	$53.2M	Sell	580,600 -200	-0%	-$18.4K	1.68%	20
2013 Q3	$50.4M	Sell	580,800 -2,150	-0.4%	-$193K	1.73%	20
2013 Q2	$50.1M	Buy	+582,950	New	+$49.5M	1.79%	18

Other funds holding JNJ

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Markel Group's JNJ Position: Q2 2026 in Review

Markel Group held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 610,800 shares worth $155M. The position accounts for 1.18% of the portfolio, ranked #24.

Markel Group first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,648 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Markel Group held 610,800 shares of Johnson & Johnson worth $155M as of Q2 2026.
Markel Group left its Johnson & Johnson share count unchanged in Q2 2026.
Johnson & Johnson made up 1.18% of Markel Group's portfolio in Q2 2026, its #24 holding.
Markel Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
2,648 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Markel Group's 13F filing for Q2 2026, filed 31 Jul 2026.